Eucrisa (crisaborole) NDC 55724-211

NDC codes

FDA NDC Directory

Product NDC (as listed)55724-211Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55724-0211Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55724-211-11	55724021111	1 TUBE in 1 CARTON (55724-211-11) / 100 g in 1 TUBEMarketed from Jan 30, 2017
55724-211-21	55724021121	1 TUBE in 1 CARTON (55724-211-21) / 60 g in 1 TUBEMarketed from Jan 30, 2017
55724-211-23	55724021123	1 TUBE in 1 CARTON (55724-211-23) / 60 g in 1 TUBEMarketed from Jan 30, 2017
55724-211-42	55724021142	6 TUBE in 1 CARTON (55724-211-42) / 2.5 g in 1 TUBEMarketed from Jan 30, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Eucrisa
Generic name (nonproprietary): crisaborole
Active ingredients: Crisaborole — 20 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Pfizer Laboratories Div Pfizer Inc
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 207695
Marketing start: Jan 30, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Phosphodiesterase 4 Inhibitors (Mechanism)
Identifiers: Product ID 55724-211_e5457495-d465-4c0a-a1ea-603c4c5823fbSPL ID e5457495-d465-4c0a-a1ea-603c4c5823fbSPL set ID 609b77de-1ca3-4783-b8f5-01a9c0f1d77dRxCUI 1865957, 1865962UNII Q2R47HGR7P
Pharmacologic class: Phosphodiesterase 4 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455724021111 followed by a unit qualifier and the quantity

Package 55724-0211-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 23, 2025.

Indications (excerpt from the label)

EUCRISA is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older. EUCRISA is a phosphodiesterase 4 inhibitor indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)